Imagion Biosystems Limited (ASX: IBX) (the Company), had former GE Healthcare executive and Non-Executive Director, Mike Harsh, speak to Scott Power on the Under the Microscope Podcast. In the first part of the interview, Mike talked about what attracted him to Imagion Biosystems, and why MagSense is set to significantly change medical imaging and cancer detection. Speaking in part two of the Under The Microscope podcast, Mike also shares his thoughts on the future of the medical imaging industry.
To hear the first part of the interview, please click through here. And the hear part two of the interview, please click through here.
Quarterly Activity Report – Quarter ending 31 December 2023
Highlights: Announced positive results from IBI10103 Phase I Study demonstrating safety and clinical feasibility of molecular MRI with MagSense® HER2 Imaging Agent Presented new animal